Abstract

Metabolic diseases like diabetes mellitus or dyslipidemia have a complex etiology characterized by the interference of genetic predisposition and environmental factors like diet or lifestyle. Over time they can cause significant vascular complications, leading to dysfunction or failure of key organs (brain, heart), with possible fatal consequences or a severe reduction of life quality. Although current authorized drugs may successfully control blood glucose or cholesterol level, their use is often associated with severe side effects, therefore the development of new drug candidates is necessary for a better management of metabolic diseases. Among potential new drug sources, aromatic plants rich in essential oils like Melissa officinalis L., Mentha x piperita L., Cuminum cyminum L. or Pistacia lentiscus L. var. chia are very promising due to their diverse chemical composition and multiple mechanisms of action. This review describes a series of recent experimental studies investigating antidiabetic and hypolipemic effects of essential oils extracted from several aromatic plant species with an ethnopharmacological relevance in the Balkan peninsula. The pharmacological models used in the studies together with the putative mechanisms of action of the main constituents are also detailed. The presented data clearly sustain a potential administration of the studied essential oils for the prevention and treatment of metabolic diseases. Further research is needed in order to ascertain the therapeutic importance of these findings.

Highlights

  • Metabolic diseases have a complex etiology dominated by genetic predisposition and environmental factors like diet or lifestyle (Barroso and McCarthy, 2019)

  • Significant reduction of total cholesterol and low-density lipoproteins (LDL) Reduction of fasting blood glucose and total cholesterol extracted from the black cumin (Nigella sativa L.)

  • This review identified sixteen essential oil-bearing plant species from Balkan region with antidiabetic and antihyperlipidemic effects demonstrated in preclinical and clinical studies

Read more

Summary

Introduction

Metabolic diseases have a complex etiology dominated by genetic predisposition and environmental factors like diet or lifestyle (Barroso and McCarthy, 2019). The most important metabolic diseases with a significant impact on global health are diabetes mellitus (type 1 or insulin-dependent and type 2 or non-insulindependent) and dyslipidemias (hypercholesterolemia, hypertriglyceridemia, and mixed dyslipidemia). Dyslipidemia is a major risk factor for ischemic heart disease and stroke, causing 2.6 million deaths and 29.7 million disability adjusted life years (DALYS) in 2008 (World Health Organization, 2008). Chronic hyperglycemia or hypercholesterolemia associated with the two diseases which can coexist, can cause significant vascular complications, leading to dysfunction or failure of multiple organs (brain, heart, kidneys), with possible fatal consequences or a severe reduction of life quality (De Fronzo et al, 2015)

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call